Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioadaptives Inc (OP: BDPT )

0.0004 -0.0001 (-20.00%)
Streaming Delayed Price Updated: 2:27 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,742,000
Open 0.0005
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0005
Today's Range 0.0004 - 0.0005
52wk Range 0.0003 - 0.0060
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioAdaptives, Inc. Announces NaturaComplete, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System
Edward Jacobs, M.D., BioAdaptives CEO, comments, “NaturaComplete™ is derived from research conducted over the past seven years and is based on the idea that a single, comprehensive blend of synergistic... 
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
-55.56%
-55.56%
6 Month
-63.64%
-63.64%
1 Year
-42.86%
-42.86%

More News

Read More
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioAdaptives Announces Nationwide Launch of Lung Fortress(TM) Natural Supplement
Via ACCESSWIRE
BioAdaptives' Subsidiary, Livestock Impact, Inc., Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products
Via NewMediaWire
Topics Retirement
Exposures Pension
BioAdaptives' Subsidiary, Livestock Impact, Inc., Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products
Via TheNewswire.com
Topics Retirement
Exposures Pension
BioAdaptives Announces Signing of a New Distributors Agreement for AI Body Composition Measuring App and New Weight Management System
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioAdaptives, Inc. Introduces PROTEINnMORETM Ahead of 2024 Launch of AI-based "Fit Your Outfit" app
Via NewMediaWire
BioAdaptives Announces Special Holiday Wellness Offers and Gift
Via NewMediaWire
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula
Via NewMediaWire
BioAdaptives Highlights Continued Success of Popular LUNG ARMOR System as US Enters Flu Season
Via NewMediaWire
Exposures COVID-19
BioAdaptives Takes Aim at Safe Pain Management with All-Natural Supplement
Via NewMediaWire
BioAdaptives Targets Multi-Billion Dollar Sleep Market with SleepEZ Natural Supplement
Via NewMediaWire
BioAdaptives, Inc. Celebrates Nine Years of Commercial Success in Equine Nutrition
Via NewMediaWire
BioAdaptives, Inc. Commences Development of a New Supplement for Women's Health
Via NewMediaWire
BioAdaptives, Inc. Redefines Its Expanding Role of Providing Innovative Human Health Products While Its Wholly Owned Subsidiary, LiveStock Impact, Inc., Targets Animal Health and Botanical Drugs
Via NewMediaWire
LiveStock Impact, Inc., a Wholly Owned Subsidiary of BioAdaptives, Inc., Announces the Appointments of two Experts to Board of Directors
Via NewMediaWire
BioAdaptives, Inc. Announces the Spin-off Its LiveStock Impact Division as a Wholly Owned Subsidiary, LiveStock Impact, Inc., Focusing on New Product Development and Global Marketing of Animal Health Supplement Products and Botanical Drugs
Via NewMediaWire
OTC Stocks to Watch in August 2023: HNRC, BDPT, ENZC, AABB, SNNC
Via AB Newswire
BioAdaptives, Inc. Announces Intention to Spin off Its Livestock Impact Division as a Wholly-owned Subsidiary With Further Expansion in Botanical Drug Development and Animal Health Markets
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Bioavailable Resveratrol for Both Animals and Humans
Via NewMediaWire
BioAdaptives Inc. (OTC BDPT) Announces New Appointment to the Board of Directors - Visionary Futurist, Wellness Pioneer and Marketer, David Allen, PhD
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
BioAdaptives, Inc. (OTC BDPT) Announces the Appointment of Flying C Bar Ranch Therapy Division as Its Exclusive Marketing Agent for Its LiveStock Impact Line of Performance Equine and Pet Supplements
Via NewMediaWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.